220 related articles for article (PubMed ID: 30927483)
1. High rates of indeterminate interferon-gamma release assays for the diagnosis of latent tuberculosis infection in liver transplantation candidates.
Wigg AJ; Narayana SK; Anwar S; Ramachandran J; Muller K; Chen JW; John L; Hissaria P; Kaambwa B; Woodman RJ
Transpl Infect Dis; 2019 Jun; 21(3):e13087. PubMed ID: 30927483
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON
Hand J; Sigel K; Huprikar S; Hamula C; Rana M
Transpl Infect Dis; 2018 Apr; 20(2):e12845. PubMed ID: 29359834
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the 2-step tuberculin skin test and the quantiFERON-TB Gold In-Tube Test for the screening of tuberculosis infection before liver transplantation.
Casas S; Muñoz L; Moure R; Castellote J; Guerra MR; Gonzalez L; Andreu A; Rafecas AG; Alcaide F; Santin M
Liver Transpl; 2011 Oct; 17(10):1205-11. PubMed ID: 22279622
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients.
Edathodu J; Varghese B; Alrajhi AA; Shoukri M; Nazmi A; Elgamal H; Aleid H; Alrabiah F; Ashraff A; Mahmoud I; Al-Hajoj S
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28170135
[TBL] [Abstract][Full Text] [Related]
5. Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study.
Theodoropoulos N; Lanternier F; Rassiwala J; McNatt G; Preczewski L; DeMayo E; Stosor V; Ison MG
Transpl Infect Dis; 2012 Feb; 14(1):1-8. PubMed ID: 21883759
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
7. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
Ryu MR; Park MS; Cho EH; Jung CW; Kim K; Kim SJ; Oh HY; Huh W; Jang HR; Koh WJ; Park HY; Kim YH; Sinn DH; Choi JO; Joh JW; Kim JM; Kim SJ; Park JB; Kang ES
J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226
[TBL] [Abstract][Full Text] [Related]
8. Latent Tuberculosis screening using interferon-gamma release assays in an Australian HIV-infected cohort: is routine testing worthwhile?
Doyle JS; Bissessor M; Denholm JT; Ryan N; Fairley CK; Leslie DE
J Acquir Immune Defic Syndr; 2014 May; 66(1):48-54. PubMed ID: 24457631
[TBL] [Abstract][Full Text] [Related]
9. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
10. The use of a borderline zone for the interpretation of interferon-gamma release assay results for serial screening of healthcare workers.
Park JH; Kim N; Park H; Kim TS; Park SW; Roh EY; Yoon JH; Shin S
PLoS One; 2020; 15(6):e0235254. PubMed ID: 32603343
[TBL] [Abstract][Full Text] [Related]
11. Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.
Cho H; Kim YW; Suh CH; Jung JY; Um YJ; Jung JH; Kim HA
Lupus; 2016 Oct; 25(12):1341-8. PubMed ID: 26985011
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
[TBL] [Abstract][Full Text] [Related]
13. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.
Blount RJ; Tran MC; Everett CK; Cattamanchi A; Metcalfe JZ; Connor D; Miller CR; Grinsdale J; Higashi J; Nahid P
BMC Public Health; 2016 Aug; 16(1):875. PubMed ID: 27558397
[TBL] [Abstract][Full Text] [Related]
15. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
[TBL] [Abstract][Full Text] [Related]
16. Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis.
Zhou G; Luo Q; Luo S; Chen H; Cai S; Guo X; He J; Xia Y; Li H; Zhou Y; Zhang Y; Song C
Front Immunol; 2023; 14():1170579. PubMed ID: 37256138
[TBL] [Abstract][Full Text] [Related]
17. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
[TBL] [Abstract][Full Text] [Related]
18. Positivity rate of interferon-γ release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan.
Igari H; Akutsu N; Ishikawa S; Aoyama H; Otsuki K; Hasegawa M; Maruyama M; Tsuyuzaki M; Suzuki K; Saigo K
J Infect Chemother; 2019 Jul; 25(7):537-542. PubMed ID: 30905632
[TBL] [Abstract][Full Text] [Related]
19. QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TB.
Ahmadinejad Z; Azmoudeh Ardalan F; Razzaqi M; Davoudi S; Jafarian A
Transpl Infect Dis; 2013 Feb; 15(1):90-5. PubMed ID: 23173720
[TBL] [Abstract][Full Text] [Related]
20. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil.
Costa AG; Carvalho BKS; Araújo-Pereira M; Ibiapina HNS; Spener-Gomes R; Souza AB; Gomes-Silva A; Andrade AMS; Silva EC; Arriaga MB; Benjamin A; Rocha MS; Moreira ASR; Oliveira JG; Figueiredo MC; Turner MM; Durovni B; Cavalcante S; Kritski AL; Rolla VC; Sterling TR; Andrade BB; Cordeiro-Santos M;
Microbiol Spectr; 2021 Dec; 9(3):e0116321. PubMed ID: 34851140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
